GLP-1 Agonists & Muscle Loss Part 2: Why Clinical Assessment Must Go Beyond the Scale
The Hidden Risks Behind Rapid Weight Loss GLP-1 receptor agonists (GLP-1RAs), including semaglutide, have rapidly become central to the management of obesity and type 2 diabetes, delivering substantial and sustained weight loss alongside important cardiometabolic benefits. However, rapid weight loss does not often equate to healthy weight loss. A meaningful proportion of weight reduction achieved […]